1,100-Patient study aims to predict repeat heart ablation success
NCT ID NCT07185412
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study will follow 1,100 people with atrial fibrillation who have a pulsed field ablation procedure. The goal is to find out which patient traits and procedure details make a repeat ablation more likely. Researchers will track heart rhythm problems and side effects for one year. This is an observational study, so it does not test a new treatment but aims to improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Pulsed field ablation (a device procedure that uses electrical pulses to treat atrial fibrillation)
What this could lead to
If successful, this could help doctors identify which patients are likely to need a repeat ablation, improving treatment planning for atrial fibrillation.
What could go wrong
This is an observational study, not a treatment trial. It will not test a new therapy, and results may not change current practice. The findings depend on real-world data, which can be inconsistent.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Unidad de Arritmias. Departamento de Cardiología. Hospital Universitario Lozano Blesa.
Zaragoza, Zaragoza, 50009, Spain
Contact Phone: •••-•••-••••